NASDAQ

InspireMD Inc. (NSPR)

554 Thanks from members

InspireMD Inc. (NSPR) faces intense market scrutiny following a voluntary U.S. recall of its CGuard Prime 135 cm delivery system, dragging gross margins to -43.7% and triggering a 20% workforce reduction, though international revenue grew 21% year-over-year.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →